The Accelerator Award enables team science across Europe. Funded through a partnership between Cancer Research UK, AIRC and FC AECC, it supports the creation of high quality tools and resources that will unlock new research into unanswered questions about cancer.
The project, led by Professor Jesús San Miguel at Clínica Universidad de Navarra, is a collaboration of 13 Research Institutions from the UK, Spain and Italy focused on improving early detection and intervention of blood cancers, mainly Monoclonal Gammopathies, Leukemia and Lymphoma.
The overall goal of the project is to better characterise the initial stages of these cancers, to help develop new precision therapies that shift the current treatment of these three blood cancer groups: focus on treating the cause of the disease, rather than the symptoms. This will help also tailoring treatments that manage minimal residue diseases (cancerous cells that remain after treatment), instead of waiting for a relapse.